JZYY(SH:600750)2021-10-27 16:00Financial Performance - The company's operating revenue for Q3 2021 was ¥671,621,213.03, representing a year-on-year increase of 16.46%[7] - The net profit attributable to shareholders for Q3 2021 was ¥145,264,068.66, with a year-on-year growth of 13.45%[7] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥125,433,613.19, reflecting an 8.86% increase compared to the same period last year[7] - Total operating revenue reached ¥1,937,836,872.68, an increase from ¥1,735,158,093.44, representing a growth of approximately 11.7% year-over-year[57] - Net profit for the period was ¥466,437,225.31, compared to ¥410,799,666.67, indicating a growth of approximately 13.5% year-over-year[61] - Basic earnings per share increased to ¥0.72 from ¥0.63, marking a rise of about 14.3% year-over-year[63] - The company reported a profit before tax of ¥556,267,148.77, up from ¥487,477,675.55, representing an increase of about 14.1% year-over-year[61] - The total comprehensive income for the period was ¥466,437,225.31, compared to ¥410,799,666.67, indicating a growth of approximately 13.5% year-over-year[63] Assets and Liabilities - The total assets at the end of the reporting period amounted to ¥5,147,517,955.61, an increase of 4.55% from the end of the previous year[10] - The total current assets increased to CNY 3,490,168,938.52 compared to CNY 3,275,216,063.89 at the end of 2020, reflecting a growth of approximately 6.55%[48] - The total liabilities amounted to CNY 679,075,934.40, slightly up from CNY 672,273,995.31 in the previous year[53] - The company's equity attributable to shareholders increased to CNY 4,085,332,676.23 from CNY 3,876,867,968.11, representing a growth of about 5.39%[53] - The total non-current assets slightly increased to CNY 1,657,349,017.09 from CNY 1,648,357,771.16 year-over-year[51] Shareholder Information - The total number of common shareholders at the end of the reporting period is 48,370[19] - The largest shareholder, China Resources Jiangzhong Pharmaceutical Group Co., Ltd., holds 271,071,486 shares, accounting for 43.03% of total shares[19] - The company repurchased a total of 6,300,042 shares, representing 1.00% of the total share capital, with an average repurchase price of 11.63 RMB per share[23] - The highest price during the share repurchase was 11.88 RMB per share, and the lowest was 11.34 RMB per share[23] Wealth Management and Investments - The company has entrusted a total of 300 million RMB in wealth management with a floating income type, achieving an annualized return rate of 3.35%[31] - Another wealth management amounting to 100 million RMB was entrusted, also with a floating income type, yielding an annualized return of 3.50%[31] - A total of 150 million RMB was invested in a floating income wealth management product, with an actual return of 5,134,931.51 RMB, reflecting a 3.50% annualized return[31] - The company has diversified its investments across multiple banks, ensuring a balanced portfolio with varying return rates[35] - The total expected return from various wealth management products is projected to be substantial, with actual returns being closely monitored[31] - The company continues to explore new wealth management opportunities to enhance its financial performance[31] Legal and Compliance - The company’s legal department has filed a lawsuit to recover overdue loan amounts from Changrong Automobile[28] - The company has received approval from the State-owned Assets Supervision and Administration Commission for the implementation of the restricted stock incentive plan[24] - The company has implemented new leasing standards starting from 2021, affecting the financial statements[68] - The company confirmed the recognition of right-of-use assets and related lease liabilities under the new leasing standard[73] Research and Development - Research and development expenses rose to ¥47,762,731.83 from ¥33,740,433.65, showing an increase of approximately 41.5% year-over-year[57]